Tech Company Financing Transactions
Modis Therapeutics Funding Round
F-Prime Capital, OrbiMed and Aceras BioMedical joined a $30 million Series A funding round for Modis Therapeutics. The financing round was announced on 10/2/2018.
Transaction Overview
Company Name
Announced On
10/2/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
409 13th St. 700
Oakland, CA 94612
USA
Oakland, CA 94612
USA
Phone
Website
Email Address
Overview
Modis Therapeutics was formed in 2016 through a collaboration with academic experts in mitochondrial biology to develop disease-modifying therapies for rare genetic diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Grass
Chief Medical Officer
Joanne Quan
Vice President
Daniel DiPietro
Vice President
Stacey Harte
Vice President
Laurie Tsuruda
VP - Bus. Development
Peter Barber
VP - Finance
Aaron Mishel
VP - Manufacturing
Paul Glidden
Browse more venture capital transactions:
Prev: 10/2/2018: Re:Store venture capital transaction
Next: 10/2/2018: project44 venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs